Welder’s Anthrax Treated with Obiltoxaximab — Louisiana, 2024
Julie M. Thompson, Theresa Sokol(Louisiana State Department of Health and Hospitals), James M. Antonini(National Institute for Occupational Safety and Health), Julie Hand, William A. Bower(National Center for Emerging and Zoonotic Infectious Diseases), Caitlin M. Cossaboom(Centers for Disease Control and Prevention), Marie A. de Perio(National Institute for Occupational Safety and Health), Karl Feldmann, Patricia Yu(Centers for Disease Control and Prevention), Chad Dowell, Abigail Cocco, Danielle Haydel(Louisiana State Department of Health and Hospitals), Eric W. Lundstrom(Centers for Disease Control and Prevention), Dawn Blackburn(Department of Human Services), Caroline A. Schrodt, Taylor K. Paisie, Yon Yu(Department of Human Services), Zachary P. Weiner, Cari A. Beesley, Chung K. Marston(Centers for Disease Control and Prevention), Alex R. Hoffmaster(National Center for Emerging and Zoonotic Infectious Diseases), Rebecca Zaayenga, Maren Bell-Do, Lindsay D. Hein, Katherine M. DeBord, Latira Haynes, Michael Bacon, Christopher A. Gulvik(Centers for Disease Control and Prevention), Brian T. Richardson, Nancy Burton
Cited by 0
Related Papers
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
|JAMA Internal Medicine|2020|747
Monkeypox Outbreak — Nine States, May 2022
|MMWR Morbidity and Mortality Weekly Report|2022|309
Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021
|MMWR Morbidity and Mortality Weekly Report|2022|277
Nonfoodborne<i>Vibrio</i>Infections: An Important Cause of Morbidity and Mortality in the United States, 1997–2006
|Clinical Infectious Diseases|2008|206